返回
HPDAF: A Practical Tool for Predicting Drug-Target Binding Affinity Using Multimodal Features
DOI:10.1016/j.ejmech.2025.118153.png)
摘要
En 中文
• HPDAF框架通过双重注意力机制融合蛋白质、药物和结合口袋特征。
• 在关键数据集上超越最新先进模型,具有更高的CI、R值和更低的误差指标。
• EGFR案例研究将模型注意力与药效基团联系起来,有助于药物设计。
• 开源指南使药物化学家能够使用HPDAF进行筛选和优化。
期刊
IF:
5.9
论文数:
1.7W
被引数:
6.0W
机构
引用论文
RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy
NUCLEIC ACIDS RESEARCH
IF13.1
SimBoost: a read-across approach for predicting drug-target binding affinities using gradient boosting machinesSimBoost: 一种使用梯度增强机器预测药物-靶标结合亲和力的跨读方法
SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules微笑,一种化学语言和信息系统。1.介绍方法和编码规则
GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual informationGsaml-dta: 基于自注意机制和互信息的图神经网络的可解释药物-靶标结合亲和力预测模型
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-20182009-2018估计将新药推向市场所需的研发投资

